Introduction: Breast cancer is the most common cancer-affecting women worldwide. Western current perspectives are starting to comprehend cancer as a systemic disease from the start. In TCM, the formation of cancer is associated energy deficiencies with Heat retention. Spleen deficiency is one of the major causes of formation of Phlegm leading to the formation of tumors. There are studies associating the five elements in TCM with chakras’ energy centers and measuring the chakra, the author will be measuring the internal massive organs energy.

Purpose: To demonstrate that there is chakras’ energy deficiencies chronically present in the body of the patient with breast cancer. Also, to analyze the importance of treating the subject systemically, through the replenishment of chakras’ energy centers.

Methods: two cases report, both were female patients (42 and 56years old), with the diagnosis stress and anxiety in the first and the second with diagnosis of sub retinal fluid retention, both patients with past history of breast cancer twenty and six years ago, removed with surgery. Chakras’ energy measurement through radiesthesia procedure was done. Results: all the chakras were in the lowest level of energy, rated in one out of eight.

Conclusion: Patients with history of breast cancer have chakras’ energy centers deficient in energy and the replenishment of these chakras is the major importance to prevent future formation of metastasis, new cancer in other sites or the formation of any chronic diseases.

Breast cancer is a very important problem for women in the word, where cancer prevalence is gradually increasing. Breast cancer accounts for 23% of all cancer cases and 14% of deaths due to cancer among women. Many advances in cancer diagnosis and treatment have, of course, reflected on breast cancer. In fact, it would not be wrong to say that breast cancer is one of the pioneers of this development. The chance of success in treating breast cancer is directly related to how early the cancer is caught. When detected at an early stage, the 5-year survival rate can reach 96 percent. Breast cancer treatment is done according to the stage of breast cancer and the current health status of the patient. Although the priority in the treatment is the protection of the breast tissue, the breast tissue can be completely removed with the mastectomy procedure when necessary. After surgery, radiotherapy and chemotherapy may be required. In studies, the preliminary results of which have been recently reported, biological agent combinations, including trastuzumab, will have an important place among the treatment strategies that will be determined according to the molecular properties of tumors in the future. In parallel with the development of nanotechnological methods, reconstructing or newly discovered drugs can be applied like a guided missile, targeting only cancer cells, without damaging living cells, will be a very important step in cancer treatment strategies in the near future. Our longer-term goal is to map each cancer separately and to treat it with the cancer-specific treatment method that each patient carries. In this way, it will be possible for each patient to create a three-dimensional information technology network that includes the genetic characteristics of cancer, the prevalence of the disease in the body, its stage and treatment features. If we can take this one step further, thanks to the international information sharing, it will be possible for each patient to have the opportunity to easily access special treatments for him / her, no matter where they are, together with their physician. We observe with excitement and pleasure that, with the rapid introduction of important developments that could make a difference in breast cancer treatment, we progressed step by step towards "personalized" treatment for our patients.